Literature DB >> 20002544

Polyphosphate binds with high affinity to exosite II of thrombin.

N J Mutch1, T Myles, L L K Leung, J H Morrissey.   

Abstract

BACKGROUND: Polyphosphate (a linear polymer of inorganic phosphate) is secreted from platelet dense granules, and we recently showed that it accelerates factor V activation by thrombin.
OBJECTIVE: To examine the interaction of polyphosphate with thrombin. METHODS AND
RESULTS: Thrombin, but not prothrombin, altered the electrophoretic migration of polyphosphate in gel mobility assays. Thrombin binding to polyphosphate was influenced by ionic strength, and was evident even in plasma. Two positively charged exosites on thrombin mediate its interactions with other proteins and accessory molecules: exosite I (mainly with thrombin substrates), and exosite II (mainly with certain anionic polymers). Free thrombin, thrombin in complex with hirudin's C-terminal dodecapeptide and gamma-thrombin all bound polyphosphate similarly, excluding exosite I involvement. Mutations within exosite II, but not within exosite I, the Na(+)-binding site or hydrophobic pocket, weakened thrombin binding to polyphosphate as revealed by NaCl dependence. Surface plasmon resonance demonstrated tight interaction of polyphosphate with thrombin (K(d) approximately 5 nm) but reduced interaction with a thrombin exosite II mutant. Certain glycosaminoglycans, including heparin, only partially competed with polyphosphate for binding to thrombin, and polyphosphate did not reduce heparin-catalyzed inactivation of thrombin by antithrombin.
CONCLUSION: Polyphosphate interacts with thrombin's exosite II at a site that partially overlaps with, but is not identical to, the heparin-binding site. Polyphosphate interactions with thrombin may be physiologically relevant, as the polyphosphate concentrations achievable following platelet activation are far above the approximately 5 nM K(d) for the polyphosphate-thrombin interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002544      PMCID: PMC2856763          DOI: 10.1111/j.1538-7836.2009.03723.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  33 in total

1.  Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin.

Authors:  M Tsiang; A K Jain; C S Gibbs
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

2.  Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII.

Authors:  C T Esmon; P Lollar
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

3.  Molecular mapping of the heparin-binding exosite of thrombin.

Authors:  J P Sheehan; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

4.  Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation.

Authors:  L W Liu; A R Rezaie; C W Carson; N L Esmon; C T Esmon
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

5.  Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101.

Authors:  J Ye; A R Rezaie; C T Esmon
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

6.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

7.  Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III.

Authors:  Z R Gan; Y Li; Z Chen; S D Lewis; J A Shafer
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

8.  Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.

Authors:  M C Bouton; M Jandrot-Perrus; S Moog; J P Cazenave; M C Guillin; F Lanza
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

9.  Preparation and use of polyphosphate-modified zirconia for purification of nucleic acids and proteins.

Authors:  B Lorenz; S Marmé; W E Müller; K Unger; H C Schröder
Journal:  Anal Biochem       Date:  1994-01       Impact factor: 3.365

10.  Crystallographic structure of human gamma-thrombin.

Authors:  T J Rydel; M Yin; K P Padmanabhan; D T Blankenship; A D Cardin; P E Correa; J W Fenton; A Tulinsky
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

View more
  21 in total

Review 1.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

2.  Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.

Authors:  J-S Bae; W Lee; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

Review 3.  From underlying chemistry to therapeutic potential: open questions in the new field of lysine polyphosphorylation.

Authors:  Amanda Bentley-DeSousa; Michael Downey
Journal:  Curr Genet       Date:  2018-06-07       Impact factor: 3.886

4.  Polyphosphate multi-tasks.

Authors:  J H Morrissey
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 5.  Polyphosphate: a link between platelets, coagulation and inflammation.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

6.  Factor XI anion-binding sites are required for productive interactions with polyphosphate.

Authors:  Y Geng; I M Verhamme; S A Smith; Q Cheng; M Sun; J P Sheehan; J H Morrissey; D Gailani
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

Review 7.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

8.  Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Georgi Georgiev; Anja Klemmer; Chelsea Brain; Paul Y Kim; Nicola J Mutch
Journal:  Blood       Date:  2016-09-30       Impact factor: 22.113

9.  Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.

Authors:  N J Mutch; E K Waters; J H Morrissey
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

10.  Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation.

Authors:  Stephanie A Smith; Sharon H Choi; Julie N R Collins; Richard J Travers; Brian C Cooley; James H Morrissey
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.